Background illustration for clinical trials search

Small Cell Lung Cancer Clinical Trials

Browse 642 small cell lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Quebec, Westbury NY, New York NY, Montreal, Norfolk VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361497

Phase3, Recruiting

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Newark DE, Baltimore MD, Washington D.C. DC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07154290

Phase2, Recruiting

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Boston MA, New York NY, Fairfax VA, Durham NC,
Sponsor: TRIANA Biomedicines, Inc.

Sex: All

Age: 18+

Code: NCT07491497

Phase1, Phase2, Recruiting

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC),
Location: Boston MA, Philadelphia PA, Fairfax VA, Tampa FL,
Sponsor: Kestrel Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07458347

Phase1, Recruiting

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07517198

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

DK222 Study at Hopkins

for
Non-Small Cell Lung Cancer, Urothelial Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT07140315

Phase1, Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Lake Success NY, Fairfax VA, Sarasota FL, Detroit MI,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase1, Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Westbury NY, New York NY, Lancaster PA, York PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase3, Recruiting

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: Mineola NY, New York NY, Durham NC, Birmingham AL,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07246863

Phase2, Recruiting

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: New Haven CT, New York NY, Durham NC, Charleston SC,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07098988

Phase2, Recruiting

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

for
Relapsed Small Cell Lung Cancer,
Location: Philadelphia PA, Salisbury NC, Pittsburgh PA,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT06681220

Phase1, Phase2, Recruiting

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer Stage II,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07428044

Phase2, Recruiting

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Boston MA, Lebanon NH, Quebec, Lake Success NY,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase3, Recruiting

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

for
Cancer, Solid Tumor Cancer, Advanced Metastatic Cancer,
Location: Fairfax VA, Plantation FL, Austin TX, San Antonio TX
Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07424547

Phase1, Recruiting

Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC

for
Non Small Cell Lung Cancer, Stage III Lung Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT06878274

Phase2, Recruiting

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

for
Non-small Cell Lung Cancer
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT04297605

Phase1, Recruiting

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

for
Small Cell Lung Cancer (SCLC)
Location: Boston MA, Charlottesville VA, Chicago IL
Sponsor: Alliance Foundation Trials, LLC.

Sex: All

Age: 18+

Code: NCT07149363

Phase2, Recruiting

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

for
Relapsed/Refractory Small Cell Lung Cancer
Location: Durham NC, Buffalo NY, Cleveland OH, Detroit MI,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07325136

Phase1, Phase2, Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase1, Recruiting

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

for
Squamous Non-small Cell Lung Cancer
Location: Paramus NJ, Albany NY, Fairfax VA, Tampa FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07221474

Phase2, Recruiting